(Q80701381)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

main subject

irritable bowel syndrome

1 reference

Lactobacillus acidophilus

inferred from title

object named as

Lactobacillus acidophilus

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Ji Hyun Song

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Hoi Jin Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jun Haeng Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Hee Jung Son

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Dong Kyung Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Young-Ho Kim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jae J Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jong Chul Rhee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Poong-Lyul Rhee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

15 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

2714-2718

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18274900%20AND%20SRC:MED&resulttype=core&format=json

Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.

2 January 2020

cites work

1 reference

12 December 2020

Probiotics in irritable bowel syndrome: has the time arrived?

1 reference

12 December 2020

Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy

1 reference

12 December 2020

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

1 reference

12 December 2020

[Definition and epidemiology of irritable bowel syndrome]

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome

1 reference

12 December 2020

Quality of life in managed care patients with irritable bowel syndrome

1 reference

12 December 2020

Probiotics, prebiotics, and synbiotics--approaching a definition

1 reference

12 December 2020

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

1 reference

12 December 2020

Is there a role for probiotics in irritable bowel syndrome?

1 reference

12 December 2020

Design of treatment trials for functional gastrointestinal disorders

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

1 reference

12 December 2020

Defecation frequency and timing, and stool form in the general population: a prospective study

1 reference

12 December 2020

Bacterial overgrowth as a cause of irritable bowel syndrome

1 reference

12 December 2020

Recommendations for probiotic use.

1 reference

12 December 2020

Functional bowel disorders

1 reference

12 December 2020

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective

1 reference

12 December 2020

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

1 reference

12 December 2020